XTalks

JANUARY 15, 2024

From the continuing trend of the rapid adoption of AI tools to the growing use of real-world evidence (RWE) in regulatory decision-making and a focus on enhancing data integrity, find out how clinical trials will evolve in 2024 to shape the future of medical research. percent from 2023 to 2033.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

SEPTEMBER 5, 2023

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS. Speed is everything in clinical development.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.

Vaccination 133

Vaccination Vaccine Clinical Trials Clinical Trials 133

The Pharma Data

OCTOBER 21, 2020

More than two dozen researchers and experts have penned a letter to HHS Secretary Alex Azar, National Institutes of Health (NIH) officials and pharma company executives, imploring them to shed more light on the clinical trial designs for federally funded COVID-19 vaccine studies. Source link.

Vaccination 52

Vaccination Vaccine Trials Research 52

pharmaphorum

MARCH 2, 2022

Pfizer’s vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a phase 3 trial. With no approved vaccines to date, C. The only other company with a C. First, the bad news.

Vaccination 52

Vaccination Vaccine Trials Bacterium 52

World of DTC Marketing

NOVEMBER 27, 2020

SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. The American Nurses Association, a national professional organization, said one-third of its members do not intend to take the vaccine, and an additional third are undecided.

Vaccination 208

Vaccination Vaccine Pharma Companies Trials 208

Drug Discovery World

DECEMBER 7, 2022

We are excited to open up the waitlist for the next stage, and encourage people from other backgrounds to get involved, including our tech company members.” . The programme is like a vaccine – we expose leaders to trial situations to understand the root causes of how inequality manifests in the workplace and to uncover unconscious biases.

Pharma Companies 52

Pharma Companies Life Science Regulation Scientist 52

Pharmaceutical Technology

JULY 4, 2022

Although medicines tend to be excluded from trade sanctions as they cause loss of life, Russian pharma companies may struggle to secure funding in the face of economic sanctions and there may also be a disruption to non-essential medicines.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

World of DTC Marketing

SEPTEMBER 11, 2020

IN SHORT: Pharma companies have finally banded together to ask the FDA to better regulate any new drug approvals including a possible new COVID vaccine. And only about 4 in 10 would get the vaccine, even if it were free if the FDA approved it before the election. Big pharma is clearly worried.

Vaccination 297

Vaccination Vaccine FDA Approval Regulation 297

World of DTC Marketing

SEPTEMBER 28, 2020

J&J’s COVID vaccine is being promoted by the media to have a 98% immune system response. Will it lead to an early approval with limited testing or will J&J ensure the vaccine goes thru thorough testing? What exactly does that mean is still unknown as more testing is needed but will that vaccine get thorough testing?

Vaccination 163

Vaccination Vaccine Clinical Trials Clinical Trials 163

XTalks

AUGUST 27, 2020

With vaccine trials for COVID-19 ramping up and entering late stages, Johnson & Johnson has announced plans for what will be the largest Phase III trial so far for a vaccine against the novel coronavirus. This is double the enrollment that vaccine makers Moderna and Pfizer have planned for their Phase III trials.

Vaccination 52

Vaccination Vaccine Trials Clinical Trials 52

Pharmaceutical Technology

JANUARY 16, 2023

Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

pharmaphorum

SEPTEMBER 20, 2022

Ben Hargreaves highlights the innovation in vaccine delivery that could make a difference in providing low- and middle-income countries with vaccination options, as well as offer a boost to programs in higher-income countries. The question to be answered in the future will be how to improve upon existing vaccine technology.

Vaccination 98

Vaccination Vaccine Immune Response Antibody 98

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. Meanwhile, China and Russia have rolled out state-owned vaccines. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year.

Sales 137

Sales Vaccination Vaccine Marketing 137

Delveinsight

SEPTEMBER 7, 2021

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials. Recently, the US Food and Drug Administration has fully authorized its SARS-CoV-2 or COVID-19 vaccine. Recently, the US Food and Drug Administration has fully authorized its SARS-CoV-2 or COVID-19 vaccine.

Vaccination 70

Vaccination Vaccine Antibody Trials 70

pharmaphorum

DECEMBER 8, 2022

The FDA has started its review of Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, fast-tracking the biologics license application (BLA) with a decision due in May 2023. Pfizer is also developing a version of the vaccine aimed at expectant mothers, designed to protect against RSV illness in newborns.

Vaccination 57

Vaccination Vaccine FDA Approval Pharma Companies 57

pharmaphorum

FEBRUARY 14, 2022

Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used to run head-to-head trials of its experimental shingles vaccines CRV-101 and GlaxoSmithKline’s market-leading Shingrix. The cash will fund a phase 2b trial in 678 people aged over 50 that will compare CRV?101’s

Vaccination 52

Vaccination Vaccine Immune Response Trials 52

pharmaphorum

JUNE 14, 2022

Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical trials, leading to the FDA rejecting certain treatments and clarifying what is required for approval. Only last month , the US company Merck agreed to pay a potential $1.4 Evolving regulatory landscape.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Development 98

Pharmaceutical Technology

AUGUST 30, 2022

Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccination 195

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical Technology has listed some of the top API biologics companies in contract marketing based on our intel, insights and decades-long experience in the sector. The post Leading API biologics (cell, gene, vaccine and virus) companies in contract marketing appeared first on Pharmaceutical Technology.

Gene 100

Gene Marketing Vaccination Vaccine 100

pharmaphorum

MAY 20, 2022

Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services , an initiative that works with pharma companies on clinical trial recruitment and even hosts trial sites at certain retail locations. This interview has been edited for length and clarity.

Clinical Trials 89

Clinical Trials Clinical Trials Trials Clinical Research 89

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.

Clinical Trials 78

Clinical Trials Clinical Trials Trials Packaging 78

pharmaphorum

SEPTEMBER 7, 2022

Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. It impacts the makeup of our trial pools, and therefore the population-wide effectiveness of drug products.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Genetics 98

The Pharma Data

DECEMBER 21, 2020

The trial will be conducted at 10 sites across Germany and led by principal investigator Prof. The FOCUS trial is Ultimovacs’ fourth Phase II clinical trial with UV1 and comes in addition to the collaboration Phase II trial announced in May 2020. “We Mascha Binder, M.D.,

Vaccination 52

Vaccination Vaccine Trials Clinical Trials 52

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. During the course of my treatments and my trials, and afterwards, I was the expert in how I wanted to manage my life.”.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Clinical Research 93

Delveinsight

JULY 29, 2020

Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

pharmaphorum

APRIL 16, 2021

Activist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial results this year raised questions about management’s strategy to turn around the company’s fortunes. But that failed in a late-stage lung cancer trial comparing it with Keytruda in January.

Trials 67

Trials Sales Packaging Packaging 67

World of DTC Marketing

MARCH 1, 2021

Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. The employees at J&J are saying, on LinkedIn, how proud they are that their company developed a COVID vaccine. More support and improvement of processes are needed.

Vaccination 180

Vaccination Vaccine Pharma Companies Drugs 180

World of DTC Marketing

OCTOBER 13, 2020

I really don’t understand why the AMA, insurers, and pharma companies stay silent? Gallup reported that Americans’ willingness to be vaccinated against the coronavirus has dropped 11 percentage points, falling to 50% in late September. Misinformation on COVID-19 and vaccines are running rampant on social media.

Vaccination 215

Vaccination Vaccine Pharma Companies Trials 215

World of DTC Marketing

MARCH 11, 2022

3hree: Those with higher levels of trust in healthcare are more likely to be proactive about their general health, vaccinated against COVID-19, supportive of public health measures over personal freedom, and accepting of changing recommendations from healthcare officials than are low-trusting respondents.

Pharma Companies 212

Pharma Companies Vaccination Vaccine Doctors 212

pharmaphorum

JANUARY 10, 2022

The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the emergence and validation of mRNA vaccine technology to prevent disease. Pfizer already has a head start on competitors in the field, having achieved the first US FDA approval for an mRNA vaccine, alongside BioNTech.

RNA 109

RNA Vaccination Vaccine Pharma Companies 109

World of DTC Marketing

AUGUST 9, 2021

86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Doximity was flagged for having anti-vaccine information. HCPs don’t necessarily want pharma trying to sell products via social media.

Nurses 294

Nurses Marketing Pharma Companies Production 294

The Pharma Data

DECEMBER 4, 2020

After an incredible milestone for science, this week we bring our readers news from Pfizer and BioNTech on the promise of a Covid-19 vaccine result. Pfizer and BioNTech achieve first authorization use for their Covid-19 vaccine in the UK. Our aim is to bring a safe and effective vaccine upon approval to the people who need it.

Vaccination 52

Vaccination Vaccine Pharma Companies Medicine 52

World of DTC Marketing

JANUARY 28, 2021

At first thought, people might be thanking pharma companies for developing COVID-19 vaccines and they would be partly right. The truth is that these companies are going to make billions of dollars. Now, the US government has paid again for this vaccine through a $3.2 Please read that again. With many in the U.S.

Vaccination 180

Vaccination Vaccine Manufacturing Scientist 180

Pharmaceutical Technology

JULY 21, 2022

In 2010, only eight big pharma companies had an access strategy for low- and middle-income countries, but today, 17 of the biggest 20 companies do. In response to the Ukraine crisis, many pharma companies are ensuring a supply of essential medicine to Ukraine and surrounding countries. Drug pricing and gouging.

Pharma Companies 130

Pharma Companies Clinical Trials Clinical Trials Drugs 130

The Pharma Data

DECEMBER 16, 2020

AstraZeneca has seen a few setbacks with the COVID-19 vaccine it has developed with Oxford University, including a confusing efficacy outcome that resulted from the inclusion of a half-dose. Despite those setbacks, the company anticipates its vaccine could be available for use in the United Kingdom within the next several weeks.

Vaccination 52

Vaccination Vaccine DNA Antibody 52